Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

H. Lundbeck A/S, a Valby, Denmark biopharmaceutical company, has agreed to acquire Abide Therapeutics, a San Diego, California-based clinical-stage biopharmaceutical company, for $250 million upfront and up to $150 million in future development and...

Takeda Pharmaceutical has opened a new 165,000-square-foot research facility in San Diego, California. The facility houses more 250 employees focused on specialized drug-discovery technologies and discovery research in gastroenterology and...

Allergan, which is headquartered in Dublin, Ireland and operates four facilities in Ireland, has announced a EUR 65-million ($73-million) capital investment program for 2019 to facilitate the continued expansion of the company’s laboratories and...

Merck & Co. has approved a new global restructuring program, at a cost of $800 million to $1.2 billion, as part of a global initiative focused primarily on further optimizing the company’s manufacturing and supply network as well as reducing...

In tracking approvals of new molecular entities, Johnson & Johnson's Janssen Pharmaceutical gains FDA approval for Balversa (erdafitinib) for treating metastatic bladder cancer and Amgen gets the FDA nod for Evenity (romosozumab-aqqg)...